The Pharmaceuticals Division in Indonesia focuses on prescription products, especially for women’s healthcare and cardiology, specialty therapeutics in the areas of oncology, hematology and ophthalmology.

The division also comprises the Radiology Business Unit which markets contrast- enhanced diagnostic imaging equipment together with the necessary contrast agents.

With our innovative products, we seek to achieve a significant therapeutic benefit for patients, while at the same time satisfying the growing requirements of physicians and health insurers.

In Indonesia, we focus on the portfolio of our superior products to treat diseases as follows :

Reporting an Adverse Side-Effect:
http://pharma.bayer.com/report-side-effect

_{PP-GEN-ID-0028-1}